United Therapeutics (UTHR), in Collaboration with XVIVO Perfusion, Inc., Reports FDA Approval Of XPS and Steen Solution
Tweet Send to a Friend
United Therapeutics Corporation (NASDAQ: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (XVIVO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
